Clinical trials
Phase 2/3 Thrombocytopenia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 2 |
| Peking University People's Hospital | 2 |
| Bristol-Myers Squibb | 1 |
| Jinling Hospital, China | 1 |
| Ruilan Wang | 1 |
| Shandong University | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 9 |
| Sepsis | 2 |
| Anemia | 1 |
| Bone Marrow Failure Disorders | 1 |
| Hematologic Diseases | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Myelodysplastic Syndromes | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.